Patent: 6,720,001
✉ Email this page to a colleague
Summary for Patent: 6,720,001
| Title: | Emulsion compositions for polyfunctional active ingredients |
| Abstract: | The present invention provides pharmaceutical oil-in-water emulsions for delivery of polyfunctional active ingredients. The emulsions include an aqueous phase, an emulsifier, and an oil phase, wherein the oil phase includes a structured triglyceride that is substantially free of triglycerides having three C.sub.6 -C.sub.12 fatty acid moieties, or a combination of a long chain triglyceride and a polarity-enhancing polarity modifier. The present invention also provides methods of treating an animal with a polyfunctional active ingredient, using dosage forms of the pharmaceutical emulsions. |
| Inventor(s): | Chen; Feng-Jing (Salt Lake City, UT), Patel; Mahesh V. (Salt Lake City, UT) |
| Assignee: | Lipocine, Inc. (Salt Lake City, UT) |
| Application Number: | 09/420,159 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 6,720,001 |
| Patent Claims: | see list of patent claims |
Details for Patent 6,720,001
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Ferring Pharmaceuticals Inc. | NOVAREL | chorionic gonadotropin | For Injection | 017016 | January 15, 1974 | 6,720,001 | 2019-10-18 |
| Ferring Pharmaceuticals Inc. | NOVAREL | chorionic gonadotropin | For Injection | 017016 | December 27, 1984 | 6,720,001 | 2019-10-18 |
| Ferring Pharmaceuticals Inc. | NOVAREL | chorionic gonadotropin | For Injection | 017016 | February 15, 1985 | 6,720,001 | 2019-10-18 |
| Ferring Pharmaceuticals Inc. | NOVAREL | chorionic gonadotropin | For Injection | 017016 | February 16, 1990 | 6,720,001 | 2019-10-18 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
